Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mustafa Fuat Acikalin is active.

Publication


Featured researches published by Mustafa Fuat Acikalin.


International Journal of Urology | 2005

Epithelioid angiomyolipoma of the kidney

Mustafa Fuat Acikalin; Nilüfer Tel; Ülkü Öner; Özgül Paşaoğlu; Turgut Dönmez

Abstract  Epithelioid angiomyolipoma is a recently recognized variant of angiomyolipoma, which is characterized by the presence of polygonal cells with densely eosinophilic cytoplasm and varying degrees of nuclear atypia. Only a relatively small number of cases of epithelioid angiomyolipoma of the kidney have been reported in the literature. We report a case of epithelioid angiomyolipoma of the kidney that occurred in a 38‐year‐old woman. The tumor was composed of diffuse sheets of epithelioid cells, adipocytes and only scattered thick‐walled blood vessels. The epithelioid cells had pleomorphic and hyperchromatic nuclei with densely eosinophilic cytoplasm. Hemorrhage, necrotic foci and clusters of foamy macrophages were present. HMB‐45, CD117 (c‐kit) and CD68 were detected in the epithelioid cells. There was no expression of cytokeratin, epithelial membrane antigen or desmin. The patient showed no evidence of recurrence or metastatic disease 9 months after nephrectomy.


Archives of Gynecology and Obstetrics | 2011

Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors

Nurcan Uluskan Ünver; Mustafa Fuat Acikalin; Ülkü Öner; Evrim Ciftci; Sinan Özalp; Ertugrul Colak

PurposeThe diagnosis of benign and malignant uterine smooth muscle tumors depends on morphologic criteria such as nuclear atypia, coagulative tumor cell necrosis and mitotic activity. Most of these tumors are readily classifiable into benign or malignant categories using these criteria. However, the distinction between leiomyomas and leiomyosarcomas may at times be problematic. Hence, it would be useful to have additional markers which could help to distinguish these tumors. The aim of the study was to evaluate p16 and p21 expressions in uterine smooth muscle tumors and determine whether p16 and p21 have a potential value in the differential diagnosis of problematic cases. In addition, we evaluated whether the differential expression of p16 and p21 in uterine leiomyosarcomas correlated with tumor recurrence and patient survival.Methodsp16 and p21 expressions were investigated by immunohistochemistry from paraffin-embedded tissues in 53 cases of uterine smooth muscle tumors consisting of 15 cases of leiomyoma, 14 cases of atypical leiomyoma (leiomyoma with bizarre nuclei), 3 cases of smooth muscle tumor of uncertain malignant potential (STUMP) and 21 cases of leiomyosarcoma. Cases were evaluated with respect to both staining percentage and intensity.ResultsThere was a statistically significant difference in p16 and p21 staining percentage and intensity between leiomyosarcomas and the other groups. There was no difference in p16 and p21 expressions between leiomyomas, atypical leiomyomas (leiomyoma with bizarre nuclei) and STUMPs. Multivariate analysis showed that the tumor stage was the only independent significant prognostic factor for overall survival in leiomyosarcomas. Neither p16 nor p21 was correlated with disease-free or overall survival.ConclusionsOur findings suggested that p16 and p21 may be of value as an adjunct to conventional morphologic criteria in the assessment of problematic uterine smooth muscle tumors.


International Journal of Urology | 2005

Sarcomatoid carcinoma of the renal pelvis with giant cell tumor‐like features: Case report with immunohistochemical findings

Mustafa Fuat Acikalin; Sare Kabukcuoglu; Cavit Can

Abstract  Sarcomatoid transitional cell carcinoma is a rare entity, in which a malignant, overtly epithelial component coexists with areas having a sarcoma‐like appearance. Histological distinction of sarcomatoid carcinomas from carcinosarcomas is often difficult and immunohistochemistry is a helpful diagnostic adjunct in the correct diagnosis. In the present report, we describe an uncommon case of sarcomatoid transitional cell carcinoma of the renal pelvis, associated with giant cell tumor‐like features. Immunoperoxidase staining for cytokeratin was positive in spindle cell component, indicating an epithelial origin. The carcinomatous component showed a diffuse membranous reactivity for E‐cadherin, whereas the reactivity was sporadic and weaker in the sarcomatoid component, suggesting that the decrease of E‐cadherin expression might be associated with the acquisition of sarcomatous morphology. Osteoclast‐like multinucleated giant cells were positive for CD68 and negative for p53 oncoprotein, suggesting that they represent a non‐neoplastic component that is reactively induced in the tumor stroma.


Renal Failure | 2010

Acute Renal Failure under Dasatinib Therapy

Sultan Ozkurt; Gokhan Temiz; Mustafa Fuat Acikalin; Mehmet Soydan

Dasatinib is a second-generation tyrosine kinase inhibitor that is approved for the treatment of imatinib-resistant or imatinib-intolerant chronic myeloid leukemia. It has a 325 times stronger in vitro activity against to native BCR-ABL when comparing with imatinib. Little is known about the effects of dasatinib on renal function. A literature review revealed only one case with imatinib-resistant chronic myeloid leukemia that developed renal failure after being placed on dasatinib therapy. Here we report a patient with imatinib-resistant chronic myeloid leukemia who developed gastroenteritis and acute renal failure after a short time from the initiation of dasatinib therapy. After dasatinib interruption, these side effects resolved completely in days. In summary, dasatinib is a potent drug in the treatment of chronic myeloid leukemia, but close clinical monitoring and the timely interruption of the therapy in patients who developed acute renal failure are warranted.


European Archives of Oto-rhino-laryngology | 2004

Prognostic significance of Ki-67 expression for patients with laryngeal squamous cell carcinoma primarily treated by total laryngectomy

Mustafa Fuat Acikalin; Ülkü Öner; Nilüfer Tel; Özgül Paşaoğlu; Hamdi Cakli; Ertugrul Colak

The aim of this study was to determine the prognostic value of Ki-67 immunostaining in laryngeal squamous cell carcinomas. Ki-67 labeling was quantified in 63 laryngeal squamous cell carcinomas by counting at least 1,000 tumor cells in the most immunoreactive area in each sample, and the Ki-67 labeling index was calculated as a percentage. The antigen expression was compared with clinical factors, histopathological grading and prognosis. The Ki-67 mean proliferation index for all patients was 25.44% ( range, 2–75%). A significant correlation was found between Ki-67 mean proliferation index and patient age (P<0.05), T-stage (P<0.05), nodal metastasis (P=0.001) and recurrence (P<0.001). There was no significant association between the Ki-67 mean proliferation index and tumor site or histologic grade. A univariate analysis showed that the Ki-67 labeling index >21% (P<0.001), T-stage (P<0.001) and nodal metastasis (P=0.001) are determinants of recurrence. In the multivariate analysis, the Ki-67 labeling index >21% (P<0.001), T-stage (P<0.001) and nodal metastasis (P<0.05) were independent predictors of recurrence. Kaplan-Meier plots of survival in patients with Ki-67 values above and below the median (21%) of the general study population showed that a high Ki-67 labeling index correlated with a shorter disease-free survival (P<0.0001). The analysis of the Ki-67 labeling index at the time of initial surgery may be a powerful prognostic marker for patients with laryngeal squamous cell carcinoma and may be useful for selecting subgroups of patients who should be treated with more aggressive therapies.


Journal of Neurosurgery | 2009

Congenital cavernous hemangioma of the calvaria : Case report

Murat Vural; Mustafa Fuat Acikalin; Baki Adapinar; Metin Ant Atasoy

The authors present the case of a 6-month-old infant with a cavernous hemangioma of the parietal bone and discuss the radiological, operative, and pathological features and differential diagnosis of these extremely rare lesions in infants. Only 1 case of an infant with a calvarial cavernous hemangioma without intracranial invasion has previously been reported, and that case involved a 4 month old. Although a cavernous hemangioma of the calvaria is extremely rare in the newborn, this condition should be included in the differential diagnosis of calvarial lesions. During surgical treatment of calvarial cavernous hemangiomas, utmost attention should be paid to avoid blood loss, which could be fatal in infants.


Yonsei Medical Journal | 2009

Malignant myoepithelioma of the palate: a case report with review of the clinicopathological characteristics.

Mustafa Fuat Acikalin; Özgül Paşaoğlu; Hamdi Cakli; Kezban Gürbüz; Funda Canaz

A malignant myoepithelioma is one of the rarest salivary gland neoplasms which may either arise de novo or develop within a preexisting pleomorphic adenoma or benign myoepithelioma. The parotid gland is the most common primary site and the palate the most common intra-oral site of occurrence. Herein is present a case of a malignant myoepithelioma arising in the hard palate of a 79-year-old woman. The lesion had been examined by biopsy at another hospital, and diagnosed as a poorly differentiated squamous cell carcinoma. The patient underwent a wide local tumor resection. Examination of the resection specimen showed the characteristic histopathological and immunohistochemical features of a malignant myoepithelioma. Five months after the operation, the patient was well without evidence of recurrence or metastasis.


Renal Failure | 2014

Renal hemosiderosis and rapidly progressive glomerulonephritis associated with primary hemochromatosis

Sultan Ozkurt; Mustafa Fuat Acikalin; Gokhan Temiz; Olga Meltem Akay; Mehmet Soydan

Abstract Hereditary hemochromatosis leads to the accumulation of iron in many organs including the liver, spleen and heart and results in injury and dysfunction of these organs. On the other hand, iron accumulation and functional impairment in kidney is extremely rare. We report a 61-year-old male patient with hereditary hemochromatosis, in whom the renal function was deteriorated rapidly. Renal biopsy revealed crescentic glomeruli and hemosiderin accumulation in tubular epithelial cells.


Gynecologic and Obstetric Investigation | 2007

Benign Clear Cell Adenofibroma of the Ovary

Ö. Paşaoğlu; E. Çiftçi; N. Tel; S. Ozalp; Mustafa Fuat Acikalin

Most clear cell neoplasms of the ovaries are carcinomas; benign and borderline clear cell tumors are uncommon. To date, only 12 cases of benign clear cell adenofibroma have been reported in the literature. Here we report a case of benign clear cell adenofibroma of the left ovary in a 51-year-old postmenopausal woman. Histological examination revealed widely spaced simple glands embedded in a dense fibrous stroma. The glands were lined by one to two layers of cells with abundant clear cytoplasm. The nuclei were bland and uniform in size and shape. There was minimal cytologic atypia in some areas. In this article we discussed the criteria for the diagnosis of benign and borderline clear cell adenofibromas and reviewed the literature.


Pathology & Oncology Research | 2006

The nested variant of urothelial carcinoma: an aggressive tumor closely simulating benign lesions.

Emine Dundar; Mustafa Fuat Acikalin; Cavit Can

The “nested” variant is a rare form of urothelial carcinoma and its biologic behavior is highly aggressive. Herein two new cases of nested variant of urothelial carcinoma with immunohistochemical examination are presented. In one of the cases, the tumor extended through the bladder wall into the perivesicular soft tissue, prostatic urethra and left vesicula seminalis, and metastasized to obturator lymph nodes. In the other case, invasion of muscular layer was observed and three recurrences were developed during a followup period of 23 months. Both tumors of our study demonstrated high p53 and Ki-67 indices, supporting the aggressive nature of such tumors.(Pathology Oncology Research Vol 12, No 2, 105–107)

Collaboration


Dive into the Mustafa Fuat Acikalin's collaboration.

Top Co-Authors

Avatar

Melek Kezban Gürbüz

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Cavit Can

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Ercan Kaya

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Erkan Özüdoğru

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Funda Canaz

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Ertugrul Colak

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Ülkü Öner

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Baki Adapinar

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Gokhan Temiz

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Hamdi Cakli

Eskişehir Osmangazi University

View shared research outputs
Researchain Logo
Decentralizing Knowledge